Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Reconstituted aqueous solutions stored at 28 C are generally used within 1428 days for sensitive applications
Each component (BPC-157, TB-500) is not FDA-approved and was removed from 503B bulk-compounding eligibility in 2024
Key Takeaways: PRP as a First-Line Injection for Knee Osteoarthritis Stronger and longer-lasting pain relief than HA and corticosteroid injections Reduces inflammation and promotes cartilage repair , rather than just masking symptoms Potential to slow OA progression , making it a disease-modifying therapy Fewer side effects compared to corticosteroids, which can accelerate cartilage loss with repeated use Given the growing body of high-level clinical evidence , PRP is increasingly being recommended as a first-line regenerative therapy for knee osteoarthritis, offering a biological approach to symptom management and disease modification
Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts
Your dosing is personalized and overseen by our medical team based on your goals, history, and response
US$ 24.22
US$ 27.41
US$ 25.50
